ELVN EPS Estimates - Enliven Therapeutics, Inc. logo

ELVN EPS Estimates

Enliven Therapeutics, Inc.

$46.53
+$0.12(+0.26%)
42
Overall
60
Value
27
Tech
39
Quality
How is this score calculated?
Market Cap
$3.42B
Volume
933.55K
52W Range
$14.79 - $62.32
Target Price
$73.15

ELVN EPS estimates: the consensus estimate for Enliven Therapeutics, Inc.'s current fiscal year is -$1.70 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.

ELVN EPS Estimates

EPS estimate, current quarter
$-0.47
EPS estimate, next quarter
$-0.46
EPS estimate, current year
$-1.70
EPS estimate, next year
$-2.05
EPS growth, 3-year
-100.00%
ELVN reported EPS by year
Fiscal yearEPS
2025$-1.83
2024$-1.89
2023$-2.01
2022$0.24
2021$-9.48
ABCD
1SymbolPriceChangeVol
2ELVN$46.53+0.3%933.55K
3
4
5
6

Get Enliven Therapeutics, Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.